Company News-Gan & Lee

中文站

Careers | Investors | Patients and HCPS | Contact us

Careers Investors Patients and HCPS Contact us

Search

# Popular search #

Diabetes Oncology Medical Devices

Company News

Company News Exhibitions Activities

All news 2026 2025 2024 2023 2022 2021 2018

Egypt's Deputy Prime Minister Meets with Gan & Lee Delegation: China-Egypt Pharmaceutical Cooperation Reaches New Heights
Gan & Lee 2026-01-23
Gan & Lee Receives Approval for Insulin Glargine in Ethiopia, Strengthening Presence in the African Market
Gan & Lee 2026-01-21
Gan & Lee’s Ondibta® Receives EU Marketing Authorization, Becoming the First China-Developed Third-Generation Insulin to be approved for the European Market
Gan & Lee 2026-01-14
Gan & Lee Pharmaceuticals Appoints Dr. John Wang as Senior Vice President and Chief Strategy Officer to Bolster Global Business Development and Strategic Partnerships
Gan & Lee 2026-01-13
Gan & Lee Partners with Lupin Limited to Accelerate Global Rollout of Bofanglutide (GZR18) Biweekly GLP-1 RA
Gan & Lee 2025-12-29
Members of the Brazilian Diplomatic Mission Visit Gan & Lee to Explore New Opportunities for China – Brazil Diabetes Treatment Cooperation
Gan & Lee 2025-12-12

1 2 3 4 5 6 7 8 ... 20 21 >

Our websites

Gangan Technology

You are now leaving the Gan & Lee website.

The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.

Continue Back

Search

Subscribe